Aerin to Invest in Studies and New Products with $48M New Equity
Aerin Medical, a privately held medical device company focused on non-invasive procedures for treating nasal airway conditions, has closed a $48 million equity financing. Nasal airway obstruction conditions affect tens of millions of people in the U.S. annually.Aerin Medical provides...
Latest News
Largest Therapeutic Study Says Cala Trio Essential Tremor Therapy Safe and Effective
Bioelectronic medicine company, Cala Health, Inc. says its landmark PROspective study...
read the full article >
Cardiology
First Scoring Guidelines Validated for WatchPAT™ Sleep Apnea Diagnostic
Respiratory Sleep Disorder specialist, Itamar Medical Ltd. has announced publication of results of...
read the full article >
Revivent TC Less Invasive Ventricular Enhancement Therapy CE Mark Extended to 2024
read the full article >Promise for Emboliner™ Embolic Protection Catheter as Safepass 2 Study Completes Enrollment
Emboline™, Inc., developer of total embolic protection technology for transcatheter aortic valve...
read the full article >Approvals / Clearance
CE Mark for Ortho's COVID-19 IgG Antibody Test
A few weeks ago we reported that Ortho Clinical Diagnostics had seen its COVID-19 total antibody...
read the full article >
Clinical Studies / Trials
Rezūm™ Water Vapor BPH Therapy Effective After Five Years
New clinical study results say the Rezūm System provided significant, sustained improvement of...
read the full article >First Patient in SELUTION SLR™ Study for AV Fistula
MedAlliance has announced enrollment of the first patient in the SAVE* study utilizing their novel...
read the full article >